Rallybio Corp. (RLYB) - Operating Sales Margin

Rallybio Corporation (RLYB) - corporate logo

The operating profit margin chart for Rallybio Corporation (RLYB) is flattening due to the complexities of orphan drug approval and R&D expenditures. The company's foundation relies on the development of antibodies for the therapy of rare infant diseases. Current speculative risks and research costs are already priced in. The value of -4659.20 reflects this status, demonstrating the actual operating profit before tax deductions.

RLYB: Rallybio Corp Operating Profitability 07/04/2022 - 11/20/2026

Metric breakdowns and analytics for Rallybio Corporation (RLYB)

- price and consensus price forecast:
- market capitalization indicators:
Fundamental company valuation:Rallybio Corp, RLYB
Core merchandise of Rallybio Corp.

To protect capital from volatility, it is crucial for investors to evaluate cost management efficiency via the operating margin. The monopoly position of Rallybio Corporation (RLYB) in the orphan drug segment guarantees stable demand, which is reflected in the operating profit margin as an indicator of the ability to generate earnings before interest and taxes, confirming the fundamental resilience of the asset within a portfolio.

Analysis of competing companies

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|Operating Sales Margin Tonix Pharmaceuticals Inc.|Operating Profitability sxtchina.com|Operating Sales Margin Eupraxia Pharmaceuticals (EPRX)|Operating Margin BHST|EXOZ - Operating Return on Sales|Oramed - Operating Sales Margin|Entera Bio Ltd. (ENTX) - Operating Return on Sales|HYFT - Operating Profitability|ABVC: Operating Profitability|CPIX: Operating Margin|Quantum BioPharma Ltd. - Operating Profit Rate|FGEN (FibroGen Corp) - Operating Margin|Telomir Pharma (TELO) - Profitability of Operations|Operating Profitability Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Operating Profit Rate|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.